Literature DB >> 6704304

Effect of cell density on intracellular adriamycin concentration and cytotoxicity in exponential and plateau phase EMT6 cells.

S H Chambers, N M Bleehen, J V Watson.   

Abstract

The relationship between cell number and available Adriamycin (ADM) has been investigated in EMT6 cells. Results have shown that the ratio between cell number and total available ADM is important in determining in vitro ADM uptake and surviving fraction. Having established this effect, the sensitivity of exponentially growing and plateau phase EMT6 cells to ADM was investigated. ADM was assayed by extraction followed by spectrofluorimetry and also by flow cytometry (FCM); both methods were found to give the same ratio of intracellular ADM between exponentially growing and plateau phase cells. We found that for a given exposure dose plateau phase cells were more sensitive than exponentially growing cells. For the same dose per cell, plateau cells take up more ADM than exponentially growing cells. But for a given intracellular ADM concentration exponentially growing cells have a lower surviving fraction than plateau phase cells. We conclude that the surviving fraction is dependent on the proliferative state of the cells and in order to draw that conclusion it is important to relate the ADM effect on cells in vitro to the total ADM available to each cell.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6704304      PMCID: PMC1976742          DOI: 10.1038/bjc.1984.47

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  14 in total

1.  Changes in cell proliferation kinetics occurring during the life history of monolayer cultures of a mouse tumour cell line.

Authors:  P R Twentyman; J V Watson; N M Bleehen; P M Rowles
Journal:  Cell Tissue Kinet       Date:  1975-01

2.  A fluorometric assay for daunomycin and adriamycin in animal tissues.

Authors:  H S Schwartz
Journal:  Biochem Med       Date:  1973-06

3.  Survival responses of dividing and nondividing mammalian cells after treatment with hydroxyurea, arabinosylcytosine, or adriamycin.

Authors:  S C Barranco; J K Novak
Journal:  Cancer Res       Date:  1974-07       Impact factor: 12.701

4.  Resistance to adriamycin in multicellular spheroids.

Authors:  R M Sutherland; H A Eddy; B Bareham; K Reich; D Vanantwerp
Journal:  Int J Radiat Oncol Biol Phys       Date:  1979-08       Impact factor: 7.038

5.  Ethanol-induced tolerance to heat and to adriamycin.

Authors:  G C Li; G M Hahn
Journal:  Nature       Date:  1978-08-17       Impact factor: 49.962

6.  Intracellular uptake of 7-con-o-methylnogarol and adriamycin by cells in culture and its relationship to cell survival.

Authors:  B K Bhuyan; J P McGovren; S L Crampton
Journal:  Cancer Res       Date:  1981-03       Impact factor: 12.701

7.  Laser flow cytometric studies on the intracellular fluorescence of anthracyclines.

Authors:  A Krishan; R Ganapathi
Journal:  Cancer Res       Date:  1980-11       Impact factor: 12.701

8.  Flow cytometry studies of intracellular adriamycin in single cells in vitro.

Authors:  R E Durand; P L Olive
Journal:  Cancer Res       Date:  1981-09       Impact factor: 12.701

9.  Fluorescence discrimination between diploid cells on their RNA content: a possible distinction between clonogenic and non-clonogenic cells.

Authors:  J V Watson; S H Chambers
Journal:  Br J Cancer       Date:  1977-11       Impact factor: 7.640

10.  Changes in sensitivity to cytotoxic agents occurring during the life history of monolayer cultures of a mouse tumour cell line.

Authors:  P R Twentyman; N M Bleehen
Journal:  Br J Cancer       Date:  1975-04       Impact factor: 7.640

View more
  19 in total

1.  Chemosensitisation of a drug-sensitive parental cell line by low-dose cyclosporin A.

Authors:  P R Twentyman; K A Wright
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 2.  Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. II. Assay methods, adriamycin and the other antitumour antibiotics.

Authors:  A G Bosanquet
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

3.  Rapid chemosensitivity testing of human lung tumor cells using the MTT assay.

Authors:  S P Cole
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

4.  Modulation of adriamycin transport by hyperthermia as measured by fluorescence-activated cell sorting.

Authors:  G C Rice; G M Hahn
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

5.  Quantitation of cell-associated doxorubicin by high-performance liquid chromatography after enzymatic desequestration.

Authors:  A Andersen; D J Warren; L Slørdal
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

6.  The influence of tumor cell density on cellular accumulation of doxorubicin or cisplatin in vitro.

Authors:  Y Takemura; H Kobayashi; H Miyachi; K Hayashi; S Sekiguchi; T Ohnuma
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

7.  Postconfluency MDCK monolayers as an in vitro model of solid tumor chemosensitivity.

Authors:  P Skehan; J Thomas; S J Friedman
Journal:  Cell Biol Toxicol       Date:  1986-09       Impact factor: 6.691

Review 8.  Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties.

Authors:  J Bouma; J H Beijnen; A Bult; W J Underberg
Journal:  Pharm Weekbl Sci       Date:  1986-04-25

Review 9.  Kinetic resistance to anticancer agents.

Authors:  M T Dimanche-Boitrel; C Garrido; B Chauffert
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

Review 10.  Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. General considerations, the nitrosoureas and alkylating agents.

Authors:  A G Bosanquet
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.